We concluded that the ALBI score, γδ+Vδ2+PD1+ T cells (%), and γδ+Vδ2+Tim3+ T cells (%) were significantly correlated with immunotherapy efficacy for patients with advanced HCC. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.